Business Standard

Sun Pharma gains on acquisition of URL generic biz

Upon completion of the purchase, the non-colcrys generic assets of URL Pharma will be owned and managed by Caraco.

Related News

Sun Pharmaceutical Industries is trading higher by 2% at Rs 732 after the company said it has buys generic business of pharma through its subsidiary for an undisclosed amount.

“Caraco Pharmaceutical Laboratories, wholly-owned subsidiary of the company, has entered into a definitive agreement with Pharmaceuticals U.S.A., Inc, a wholly-owned subsidiary of Takeda Pharmaceutical Company, to buy the URL Pharma, Inc. generic business,” said in a statement.

Upon completion of the purchase, the non-colcrys generic assets of URL Pharma will be owned and managed by Caraco. The deal is subject to satisfaction of customary closing conditions, including applicable regulatory approvals, it added.

The stock opened at Rs 727 and hit a high of Rs 733 on the NSE. A combined 138,547 shares have changed hands on the counter in morning deals.

Read more on:   
|
|

Read More

Two entities fail to make prima facie case to revoke ban: Sebi

The Securities and Exchange Board of India (Sebi) today said the restraining order on two entities, related to plunge in some mid-cap stocks in July, ...

Quick Links

 

Market News

Cox and Kings hits new high on fund raising plans

The stock was up 6% to Rs 333, extending its previous day's 5% rally on National Stock Exchange.

Markets remain weak; Index heavyweights drag

The Sensex has dipped 29 points at 26,787 mark and the Nifty has slipped by 13 points at 8,029 levels

CARE hits record high on special dividend of Rs 65 per share

The aforesaid special dividend will be paid to the shareholders on or before October 14, 2014

Taper tantrums unlikely for Indian markets

Analysts now seem to be eyeing commentary on first interest rate hike from the US Fed meeting this week

Gold futures up marginally on global cues

Investors build fresh positions ahead of Federal Reserve meet today

Back to Top